Source:http://linkedlifedata.com/resource/pubmed/id/12353965
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
7
|
| pubmed:dateCreated |
2002-9-30
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
1539-3704
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:day |
1
|
| pubmed:volume |
137
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
625-6
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:12353965-Antibodies, Monoclonal,
pubmed-meshheading:12353965-Crohn Disease,
pubmed-meshheading:12353965-Female,
pubmed-meshheading:12353965-Humans,
pubmed-meshheading:12353965-Lupus Erythematosus, Systemic,
pubmed-meshheading:12353965-Middle Aged,
pubmed-meshheading:12353965-Tumor Necrosis Factor-alpha
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Infliximab-induced systemic lupus erythematosus.
|
| pubmed:publicationType |
Letter,
Case Reports
|